Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE ...
Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE™ (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for the treatment of ...
Pearson (FTSE: PSON.L), the world's lifelong learning company, and Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a global leader in IT services and consulting, have announced a multi-year ...
Find all the best things to do in Pittsburgh this weekend, from NatureFest to the Pittsburgh Fringe Festival to the Japanese Film Festival.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results